Contribution of Vasoactive Eicosanoids and Nitric Oxide Production to the Effect of Selective Cyclooxygenase-2 Inhibitor, NS-398, on Endotoxin-Induced Hypotension in Rats

Bahar Tunctan, Belma Korkmaz, Tuba Cuez, C. Kemal Buharalioglu, Seyhan Sahan-Firat, John Falck, Kafait Malik

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Our previous studies with the use of non-selective cyclooxygenase (COX) inhibitor, indomethacin, demonstrated that prostanoids produced during endotoxaemia increase inducible nitric oxide synthase (iNOS) protein expression and nitric oxide synthesis, and decrease cyctochrome P450 (CYP) 4A1 protein expression and CYP 4A activity. The results suggest that dual inhibition of iNOS and COX by indomethacin restores blood pressure presumably due to increased production of 20-hydroxyeicosatetraenoic acid (20-HETE) derived from CYP 4A in endotoxaemic rats. The present study examined whether increased levels of vasoconstrictor eicosanoids, 20-HETE, prostaglandin F (PGF )and thromboxane A 2 (TxA 2), would contribute to the effect of selective COX-2 inhibition to prevent endotoxin (ET)-induced fall in blood pressure associated with an increase in the production of vasodilator prostanoids, prostaglandin I 2 (PGI 2) and prostaglandin E 2 (PGE 2) and nitric oxide synthesis. Mean arterial blood pressure fell by 31 mmHg and heart rate (HR) rose by 90 beats/min. in male Wistar rats treated with ET (10 mg/kg, i.p.). The fall in mean arterial pressure and increase in HR were associated with increased levels of 6-keto-prostaglandin F (6-keto-PGF ), PGE 2, TxB 2, and nitrite in the serum, kidney, heart, thoracic aorta and/or superior mesenteric artery. Systemic and renal 20-HETE and PGF levels were also decreased in endotoxaemic rats. These effects of ET were prevented by a selective COX-2 inhibitor, N-(2-cyclohexyloxy-4-nitrophenyl)methansulphonamide (10 mg/kg, i.p.), given 1 hr after injection of ET. These data suggest that an increase in 20-HETE and PGF levels associated with decreased production of PGI 2, PGE 2, and TxA 2, and nitric oxide synthesis contributes to the effect of selective COX-2 inhibitor to prevent the hypotension during rat endotoxaemia.

Original languageEnglish (US)
Pages (from-to)877-882
Number of pages6
JournalBasic and Clinical Pharmacology and Toxicology
Volume107
Issue number5
DOIs
StatePublished - Nov 1 2010

Fingerprint

Controlled Hypotension
Eicosanoids
Cyclooxygenase 2 Inhibitors
Prostaglandins F
Endotoxins
Rats
Nitric Oxide
Blood pressure
Prostaglandins E
Arterial Pressure
Endotoxemia
Thromboxanes
Nitric Oxide Synthase Type II
Epoprostenol
varespladib methyl
Indomethacin
Prostaglandins
Heart Rate
Blood Pressure
Kidney

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Toxicology

Cite this

Contribution of Vasoactive Eicosanoids and Nitric Oxide Production to the Effect of Selective Cyclooxygenase-2 Inhibitor, NS-398, on Endotoxin-Induced Hypotension in Rats. / Tunctan, Bahar; Korkmaz, Belma; Cuez, Tuba; Kemal Buharalioglu, C.; Sahan-Firat, Seyhan; Falck, John; Malik, Kafait.

In: Basic and Clinical Pharmacology and Toxicology, Vol. 107, No. 5, 01.11.2010, p. 877-882.

Research output: Contribution to journalArticle

@article{b2e9c0b13f1a4430b74f744861d0f354,
title = "Contribution of Vasoactive Eicosanoids and Nitric Oxide Production to the Effect of Selective Cyclooxygenase-2 Inhibitor, NS-398, on Endotoxin-Induced Hypotension in Rats",
abstract = "Our previous studies with the use of non-selective cyclooxygenase (COX) inhibitor, indomethacin, demonstrated that prostanoids produced during endotoxaemia increase inducible nitric oxide synthase (iNOS) protein expression and nitric oxide synthesis, and decrease cyctochrome P450 (CYP) 4A1 protein expression and CYP 4A activity. The results suggest that dual inhibition of iNOS and COX by indomethacin restores blood pressure presumably due to increased production of 20-hydroxyeicosatetraenoic acid (20-HETE) derived from CYP 4A in endotoxaemic rats. The present study examined whether increased levels of vasoconstrictor eicosanoids, 20-HETE, prostaglandin F 2α (PGF 2α)and thromboxane A 2 (TxA 2), would contribute to the effect of selective COX-2 inhibition to prevent endotoxin (ET)-induced fall in blood pressure associated with an increase in the production of vasodilator prostanoids, prostaglandin I 2 (PGI 2) and prostaglandin E 2 (PGE 2) and nitric oxide synthesis. Mean arterial blood pressure fell by 31 mmHg and heart rate (HR) rose by 90 beats/min. in male Wistar rats treated with ET (10 mg/kg, i.p.). The fall in mean arterial pressure and increase in HR were associated with increased levels of 6-keto-prostaglandin F 1α (6-keto-PGF 1α), PGE 2, TxB 2, and nitrite in the serum, kidney, heart, thoracic aorta and/or superior mesenteric artery. Systemic and renal 20-HETE and PGF 2α levels were also decreased in endotoxaemic rats. These effects of ET were prevented by a selective COX-2 inhibitor, N-(2-cyclohexyloxy-4-nitrophenyl)methansulphonamide (10 mg/kg, i.p.), given 1 hr after injection of ET. These data suggest that an increase in 20-HETE and PGF 2α levels associated with decreased production of PGI 2, PGE 2, and TxA 2, and nitric oxide synthesis contributes to the effect of selective COX-2 inhibitor to prevent the hypotension during rat endotoxaemia.",
author = "Bahar Tunctan and Belma Korkmaz and Tuba Cuez and {Kemal Buharalioglu}, C. and Seyhan Sahan-Firat and John Falck and Kafait Malik",
year = "2010",
month = "11",
day = "1",
doi = "10.1111/j.1742-7843.2010.00589.x",
language = "English (US)",
volume = "107",
pages = "877--882",
journal = "Basic and Clinical Pharmacology and Toxicology",
issn = "1742-7835",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Contribution of Vasoactive Eicosanoids and Nitric Oxide Production to the Effect of Selective Cyclooxygenase-2 Inhibitor, NS-398, on Endotoxin-Induced Hypotension in Rats

AU - Tunctan, Bahar

AU - Korkmaz, Belma

AU - Cuez, Tuba

AU - Kemal Buharalioglu, C.

AU - Sahan-Firat, Seyhan

AU - Falck, John

AU - Malik, Kafait

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Our previous studies with the use of non-selective cyclooxygenase (COX) inhibitor, indomethacin, demonstrated that prostanoids produced during endotoxaemia increase inducible nitric oxide synthase (iNOS) protein expression and nitric oxide synthesis, and decrease cyctochrome P450 (CYP) 4A1 protein expression and CYP 4A activity. The results suggest that dual inhibition of iNOS and COX by indomethacin restores blood pressure presumably due to increased production of 20-hydroxyeicosatetraenoic acid (20-HETE) derived from CYP 4A in endotoxaemic rats. The present study examined whether increased levels of vasoconstrictor eicosanoids, 20-HETE, prostaglandin F 2α (PGF 2α)and thromboxane A 2 (TxA 2), would contribute to the effect of selective COX-2 inhibition to prevent endotoxin (ET)-induced fall in blood pressure associated with an increase in the production of vasodilator prostanoids, prostaglandin I 2 (PGI 2) and prostaglandin E 2 (PGE 2) and nitric oxide synthesis. Mean arterial blood pressure fell by 31 mmHg and heart rate (HR) rose by 90 beats/min. in male Wistar rats treated with ET (10 mg/kg, i.p.). The fall in mean arterial pressure and increase in HR were associated with increased levels of 6-keto-prostaglandin F 1α (6-keto-PGF 1α), PGE 2, TxB 2, and nitrite in the serum, kidney, heart, thoracic aorta and/or superior mesenteric artery. Systemic and renal 20-HETE and PGF 2α levels were also decreased in endotoxaemic rats. These effects of ET were prevented by a selective COX-2 inhibitor, N-(2-cyclohexyloxy-4-nitrophenyl)methansulphonamide (10 mg/kg, i.p.), given 1 hr after injection of ET. These data suggest that an increase in 20-HETE and PGF 2α levels associated with decreased production of PGI 2, PGE 2, and TxA 2, and nitric oxide synthesis contributes to the effect of selective COX-2 inhibitor to prevent the hypotension during rat endotoxaemia.

AB - Our previous studies with the use of non-selective cyclooxygenase (COX) inhibitor, indomethacin, demonstrated that prostanoids produced during endotoxaemia increase inducible nitric oxide synthase (iNOS) protein expression and nitric oxide synthesis, and decrease cyctochrome P450 (CYP) 4A1 protein expression and CYP 4A activity. The results suggest that dual inhibition of iNOS and COX by indomethacin restores blood pressure presumably due to increased production of 20-hydroxyeicosatetraenoic acid (20-HETE) derived from CYP 4A in endotoxaemic rats. The present study examined whether increased levels of vasoconstrictor eicosanoids, 20-HETE, prostaglandin F 2α (PGF 2α)and thromboxane A 2 (TxA 2), would contribute to the effect of selective COX-2 inhibition to prevent endotoxin (ET)-induced fall in blood pressure associated with an increase in the production of vasodilator prostanoids, prostaglandin I 2 (PGI 2) and prostaglandin E 2 (PGE 2) and nitric oxide synthesis. Mean arterial blood pressure fell by 31 mmHg and heart rate (HR) rose by 90 beats/min. in male Wistar rats treated with ET (10 mg/kg, i.p.). The fall in mean arterial pressure and increase in HR were associated with increased levels of 6-keto-prostaglandin F 1α (6-keto-PGF 1α), PGE 2, TxB 2, and nitrite in the serum, kidney, heart, thoracic aorta and/or superior mesenteric artery. Systemic and renal 20-HETE and PGF 2α levels were also decreased in endotoxaemic rats. These effects of ET were prevented by a selective COX-2 inhibitor, N-(2-cyclohexyloxy-4-nitrophenyl)methansulphonamide (10 mg/kg, i.p.), given 1 hr after injection of ET. These data suggest that an increase in 20-HETE and PGF 2α levels associated with decreased production of PGI 2, PGE 2, and TxA 2, and nitric oxide synthesis contributes to the effect of selective COX-2 inhibitor to prevent the hypotension during rat endotoxaemia.

UR - http://www.scopus.com/inward/record.url?scp=78649616594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649616594&partnerID=8YFLogxK

U2 - 10.1111/j.1742-7843.2010.00589.x

DO - 10.1111/j.1742-7843.2010.00589.x

M3 - Article

VL - 107

SP - 877

EP - 882

JO - Basic and Clinical Pharmacology and Toxicology

JF - Basic and Clinical Pharmacology and Toxicology

SN - 1742-7835

IS - 5

ER -